Blog
RSS FeedPosted by Michael Wonder on 08 May 2017
Southern Cross launches cover for cancer drugs not funded by PHARMAC
8 May 2017 - The frightening cost of non-PHARMAC funded cancer treatments has prompted the country's largest health insurer to ...
Posted by Michael Wonder on 08 May 2017
Proposal for various oncology medicines
8 May 2017 - PHARMAC is seeking feedback on a proposal for various oncology pharmaceuticals, including new listings and amendments ...
Posted by Michael Wonder on 29 Apr 2017
Decision to list 5-aminolevulinic acid hydrochloride (Gliolan) on the Hospital Medicines List
28 April 2017 - PHARMAC is pleased to announce that the approval of an agreement with Specialised Therapeutics Limited for ...
Posted by Michael Wonder on 26 Apr 2017
Lung cancer patients call for funded Keytruda
25 April 2017 - Patients with lung cancer say they urgently need better-funded treatments for the disease, including Keytruda. ...
Posted by Michael Wonder on 19 Apr 2017
Cancer patients want New Zealand funded treatment
20 April 2017 - Patients with a little-known cancer want a new treatment funded in this country, so they don't have ...
Posted by Michael Wonder on 10 Apr 2017
Woman's brain tumour shrunk by Keytruda
9 April 2017 - Not long ago Pamela Jones would have been told to get her affairs in order and ...
Posted by Michael Wonder on 10 Apr 2017
A look at whether your insurer will pay for what the Government won't if you get cancer
10 April 2017 - The C word – cancer – none of us want to hear it when we visit ...
Posted by Michael Wonder on 02 Apr 2017
300 cancer patients given a chance to live thanks to immunotherapy drugs
1 April 2017 - More than 300 people have been given another chance at life at a cost of more ...
Posted by Michael Wonder on 31 Mar 2017
Proposal to list 5-aminolevulinic acid hydrochloride (Gliolan) in the Hospital medicines list
31 March 2017 - PHARMAC is seeking feedback on a proposal to list 5-aminolevulinic acid hydrochloride (Gliolan) through a provisional ...
Posted by Michael Wonder on 28 Mar 2017
AIA NZ shakes up NZ’s insurance market with bolt-on cancer product
28 March 2017 - For the first time in New Zealand, families will be able to access the latest in ...
Posted by Michael Wonder on 22 Mar 2017
AIA launches insurance to pay huge costs of immunotherapy cancer drugs
22 March 2017 - Immunotherapy drugs can offer patients the chance of beating cancer, but the costs are high. ...
Posted by Michael Wonder on 13 Feb 2017
Outcomes from the November 2016 PTAC meeting
13 February 2017 - PHARMAC has published the minutes from the 3-4 November meeting. ...
Posted by Michael Wonder on 10 Feb 2017
Decision to maintain full subsidy for gefitinib (Iressa) from 1 April 2017
10 February 2017 - PHARMAC is pleased to announce the approval of a proposal to maintain full subsidy for gefitinib ...
Posted by Michael Wonder on 09 Feb 2017
Terminal cancer patient priced out of life-prolonging medication
9 February 2017 - The husband of a terminal skin cancer patient says PHARMAC are "tightarses" and life saving medication ...
Posted by Michael Wonder on 02 Feb 2017
Mind the gap - an analysis of cancer medicines in New Zealand and Australia
2 February 2017 - When it comes making a difference in people’s lives, it’s not about how many medicines you ...